Tuesday, May 4, 2021

NACI Contradicts Health Canada: Perception Management Discord for the Experimental Covid Vaccine

NACI Contradicts Health Canada- Troubles in Perception Management Campaign

The National Advisory Committee on Immunization is coming under fire after contradicting the advice Canadians have been receiving for weeks to take the first vaccine against COVID-19 that they're offered.

NACI said Monday that the Pfizer-BioNTech and Moderna vaccines are "preferred" and that Canadians should weigh the risks of waiting for one of them before deciding whether to take a more immediate jab of either of the other two approved for use in Canada.

The Johnson & Johnson and AstraZeneca vaccines have been linked to a new and extremely rare blood-clotting syndrome.
ALL AUTHORIZED (NOT APPROVED) EXPERIMENTAL VACCINES are LINKED TO VACCINE INDUCED DEADLY, LETHAL AND/OR DAMAGING BLOOD CLOTS

Astra Zeneca and J&J have a slightly higher propensity towards these deadly vaccine induced clots. But not one of them is free from this dangerous, deadly,  lethal  “side effect”

 NACI's advice appears to contradict Health Canada's long-standing recommendation that the best vaccine is the first one available.

Some (not all) doctors took to social media to denounce NACI's latest advice, warning that the committee is sowing confusion and exacerbating vaccine hesitancy.

"It pains me to say this but it's past time to take NACI's recommendations with a grain of salt," emergency physician Dr. Brian Goldman said on Twitter.

Said the physician who forgot to "do no harm"

 People who got innoculated with AstraZeneca also took to social media to express anger that they'd been hoodwinked into getting a second-rate vaccine while others questioned whether they should cancel planned first jabs of that vaccine or refuse a second dose of it.

One Twitter user noted acidly that NACI's advice boils down to "people who are most at risk should settle for a vaccine with the most risk because they are most at risk."

The risk of the new blood-clotting syndrome, known as vaccine-induced thrombotic thrombocytopenia, or VITT, is estimated to be anywhere from one case in 100,000 doses given, to one in 250,000. But the syndrome is so new, there is still little known about what the real risk is, why it is happening and who might be most likely to develop clots.

Let's restate that FACT: 

But the syndrome is so new, there is still little known about what the real risk is, why it is happening and who might be most likely to develop clots.


That’s because each and every one of these vaccines is  not tested and entirely experimental.
We’ll talk more about J & J’s vaccine sometime soon.

No comments:

Post a Comment

TROLLS &SPAM WILL BE DELETED WITHOUT HESITATION
KEEP IT RELEVANT. NO PERSONAL ATTACKS